Table 5.
Correlation analysis of renal tubular ALOX12 protein levels and clinical and pathological data.
| Parameter | r | p Value |
|---|---|---|
| DM duration (years) | −.098 | .538 |
| BMI | −.006 | .970 |
| BUN (mmol/L) | −.169 | .286 |
| CRE (µmol/L) | −.037 | .816 |
| UA (µmol/L) | −.084 | .595 |
| eGFR, mL/(min*1.73 m2) | .046 | .774 |
| HbA1c (%) | 0.074 | .639 |
| ALB (g/L) | −.109 | .491 |
| TC (mmol/L) | 0.438** | .004 |
| TG (mmol/L) | 0.186 | .238 |
| HDLC (mmol/L) | .327* | .034 |
| LHDL (mmol/L) | .316* | .041 |
| VLDL (mmol/L) | .263 | .092 |
| Apo A(g/L) | .177 | .262 |
| Apo B (g/L) | .405* | .008 |
| U-RBP (mg/L) | .412** | .007 |
| U-CYC (mg/mL) | .374* | .015 |
| Ucr (mmol/L) | −.088 | .577 |
| UACR (mg/g) | .432** | .004 |
| Glomerular lesions | .211 | .181 |
| IFTA | .347* | .024 |
| Interstitial inflammation | .317* | .041 |
| Arteriolar hyalinosis | .088 | .578 |
| Arteriosclerosis | −.039 | .807 |
BUN: blood urea nitrogen; CRE: serum creatinine; UA: uric acid; eGFR: estimated glomerular filtration rate; HbA1c: hemoglobin A1c; ALB: albumin; TC: total cholesterol; TG: triglyceride; HDLC: high-density lipoprotein cholesterol; LDLC: low-density lipoprotein cholesterol; VLDL: very low density lipoprotein; Apo A: apolipoprotein A; Apo B: apolipoprotein B; U-RBP: urinary retinol-binding protein; U-CYC: urinary cystatin c; U-Cr: urinary creatinine; U-ACR: urine-albumin/urine creatinine ratio; IFTA: interstitial fibrosis and tubular atrophy.
*
p < .05.
**
p < .01.